Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

SHBG binding properties are unchanged in male liver cirrhosis patients.

PCOS has many symptoms, with high androgen levels being the most common.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

The document explains how male reproductive hormones work and affect the body.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Topical finasteride reduces hair loss and promotes hair growth in men and women.

Taking 1mg of finasteride daily can mildly improve metabolic health and glucose regulation in men with male pattern baldness.

Acanthosis nigricans in teenage girls with PCOS is a sign of obesity, not insulin resistance or glucose intolerance.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Different PCOS types respond uniquely to infertility treatments, with some having lower pregnancy rates and higher risks of complications.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

New regenerative treatments for hair loss show promise but need more research for confirmation.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

PRP therapy helps improve hair growth and is safe for treating hair loss.

Hair analysis can somewhat track past testosterone levels but is influenced by factors like hair washing, growth rate, sex, and hair color.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.